Overview

Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
Phase:
Phase 3
Details
Lead Sponsor:
XOMA (US) LLC
Collaborator:
Institut de Recherches Internationales Servier